Figure 1.
EFS, event-free survival
Intensification studies
1 Less than or greater than 25 weeks of treatment
2–5 Additional 20 weeks of treatment
6–7 Erwina vs E.Coli-ASP
*p<0.05; **p<0.01; ***p<0.001
EFS, event-free survival
Intensification studies
1 Less than or greater than 25 weeks of treatment
2–5 Additional 20 weeks of treatment
6–7 Erwina vs E.Coli-ASP
*p<0.05; **p<0.01; ***p<0.001